Novo Nordisk
NOVO | CO
Overview
Corporate Details
- ISIN(s):
- DK0062498333 (+1 more)
- LEI:
- 549300DAQ1CVT6CXN342
- Country:
- Denmark
- Address:
- Novo Alle 1, 2880 Bagsværd
- Website:
- https://www.novonordisk.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 19:06 |
Regulatory News Service
|
English | 6.9 KB | |
| 2025-06-12 19:06 |
Regulatory News Service
|
English | 103.4 KB | |
| 2025-05-16 13:19 |
Board/Management Change
|
English | 10.2 KB | |
| 2025-05-16 13:19 |
Board/Management Change
|
English | 158.7 KB | |
| 2025-05-16 13:01 |
Board/Management Change
|
English | 158.7 KB | |
| 2025-05-16 13:01 |
Board/Management Change
|
English | 10.2 KB | |
| 2025-05-09 13:22 |
Directors' Dealings
|
English | 137.7 KB | |
| 2025-05-09 13:22 |
Directors' Dealings
|
English | 15.5 KB | |
| 2025-03-10 11:23 |
Earnings Release
|
English | 9.4 KB | |
| 2025-03-10 11:23 |
Earnings Release
|
English | 99.0 KB | |
| 2025-02-07 13:54 |
Directors' Dealings
|
English | 18.2 KB | |
| 2025-02-07 13:54 |
Directors' Dealings
|
English | 148.0 KB | |
| 2025-02-06 10:12 |
Directors' Dealings
|
English | 259.4 KB | |
| 2025-02-06 10:12 |
Directors' Dealings
|
English | 401.0 KB | |
| 2025-02-05 07:30 |
Earnings Release
|
English | 14.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM | |
|
Pharming Group N.V. | Netherlands (Kingdom of the) | PHARM | |
|
Pharnext | France | ALPHA | |
|
Pherecydes Pharma | France | ALPHE | |
|
Philogen | Italy | PHIL | |
|
Plant Advanced Technologies | France | ALPAT | |
|
Plantarc Bio Ltd. | Israel | PLNT | |
|
Pluri Inc. | Israel | PLUR |